Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Company

Company

Damien BERTRAND, Business Development Officer

DNAlytics
" Research projects : contributions to research projects with academics and hospital representatives (-omics data investigations, biomarkers and multi-marker indicators, stratification of populations, predictive models for diagnosis/prognosis, ... Development / production capabilities: internal processes and quality system compatible with ISO.13485 (medical devices). Skills and expertise: data sciences, machine learning and other technologies from artificial intelligence; statistics, bio-IT; model encapsulation into software, mobile apps or web platforms "
Funding: Prestations sub-contracted by lead researchers, or partnerships through regional/EU projects with public funding.
Publication References: Complete list on www.dnalytics.com/publications/ 
Contact : This email address is being protected from spambots. You need JavaScript enabled to view it.

Jean-Paul Deslypere, MD

Aesculape CRO Belgium BV
" Treatment of COVID 19 complications with antibodies "
Funding: partly public partly private
Contact : This email address is being protected from spambots. You need JavaScript enabled to view it. 0492 735931

Kyun Thibaut, Founder and Managing Director

Covartim
"In the global effort to help the healthcare professionals in the fight against the Covid pandemic, we are providing documents to help manufacturers that are not familiar with medical devices to properly document their work to help them in their product development and achieving compliance. These templates are derived from our technical file documentation and include some reference to guidances (mostly applicable in Belgium) for devices and accessories to answer to hospital products shortage."
Contact : Covartim www.covartim.be This email address is being protected from spambots. You need JavaScript enabled to view it.

Martin Erpicum, CEO of Mesydel and researcher

ULiège + Mesylab SRL
" How to securely return to normalcy at work? All countries consider to lift the lockdown, but few have executed it. There are no "best practices". Questions abound: What are the risks? What are the most effective measures? Will communities follow? What are the consequences for our individual lives? Who decides how to proceed? AIMS OF THE PROJECT GIGA aims at defining the best possible approach to opening up again by involving its members. Your opinion matters. GIGA has sought assistance in conducting this real time experiment from political scientists, philosophers, lawyers and medical doctors. "
Contact: This project is supported by the GIGA office and is coordinated by the ad hoc Advisory Committee made up of expert political scientists in participation (Dr. F. Thoreau, Dr. C. Parotte, Dr. P. Delvenne, Dr. C. Fallon), a political and ethicist philosopher (Dr. F. Caeymaex) and doctors (Dr. Y. Beguin, Dr. G. Darcis).

Philippe Denoel, Head of External R&D

GSK - Royal Academy of Medicine of Belgium
" Support covid international: https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/ Support covid en Belgique: https://be.gsk.com/media/915368/cp-gsk-contributions-majeures-de-gsk-a-la-lutte-contre-le-covid-19.pdf NA NA "
Funding: NA
Contact: Philippe Denoel - This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19